Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Bcl6 as a Novel Therapeutic Target in Multiple Myeloma (MM).

Teru Hideshima, M.D., Ph.D., Constantine S. Mitsiades, MD, PhD, Hiroshi Ikeda, MD, PhD, Dharminder Chauhan, PhD, Noopur Raje, M.D., Gullu Gorgun, PhD, Mariateresa Fulciniti, PhD, Diana Cirstea, MD, Giulia Perron, MD, Loredana Santo, M.D., Ayaka Hideshima, Klaus Podar, MD, MSc, PhD, Nikhil C. Munshi, MD, Paul Richardson, M.D., Ph.D., Daniel R. Carrasco, MD, PhD, Kenneth C. Anderson, MD

Blood (2009) 114 (22): 295.

https://doi.org/10.1182/blood.V114.22.295.295

Published: 2009

Journal Articles

A NOVEL Aurora A Kinase INHIBITOR MLN8237 Induces Cytotoxicity and CELL Cycle Arrest IN MULTIPLE MYELOMA.

Gullu Gorgun, PhD, Elisabetta Calabrese, MD, Teru Hideshima, MD, PhD, Jeffrey Ecsedy, PhD, Giada Bianchi, MD, Mala Mani, PhD, Madhavi Bandi, Hiroshi Ikeda, MD, PhD, Giulia Perrone, MD, Yiguo Hu, MD, PhD, Yu-Tzu Tai, PhD, Mei Zheng, Diana Cristea, MD, Loredana Santo, MD, Daniel R. Carrasco, MD, PhD, Nikhil Munshi, MD, Paul Richardson, MD, Kenneth C. Anderson, MD

Blood (2009) 114 (22): 3830.

https://doi.org/10.1182/blood.V114.22.3830.3830

Published: 2009

Journal Articles

RFP2 Knockdown Disrupts Cell Growth and Induces Apoptosis in Multiple Myeloma

Moshe E. Gatt, MD, Mala Mani, PhD, Jui Dutta, PhD, Daniel E. Carrasco, John D Shaughnessy, Jr., PhD, Kenneth C. Anderson, MD, Daniel R Carrasco, MD, PhD

Blood (2008) 112 (11): 5327.

https://doi.org/10.1182/blood.V112.11.5327.5327

Published: 2008

Journal Articles

ß-Catenin Is a Novel Marker of the Aggresome and Suggests Disruption of the Proteasome-Aggresome-Autophagasome Pathway in Multiple Myeloma In Vivo.

Kumar Sukhdeo, Mei Zheng, Teru Hideshima, MD,PhD, Kenneth C. Anderson, MD, Daniel R. Carrasco, MD,PhD

Blood (2006) 108 (11): 3449.

https://doi.org/10.1182/blood.V108.11.3449.3449

Published: 2006

Journal Articles

Clonotypic Bone Marrow-Derived Endothelial Progenitor Cells in Multiple Myeloma.

Marc J. Braunstein, MD, PhD, Daniel R. Carrasco, MD,PhD, David Kahn, MD, Kumar Sukhdeo, PhD, Alexei Protopopov, PhD, Yunyu Zhang, Kenneth C. Anderson, MD, Olcay Batuman, MD

Blood (2006) 108 (11): 3497.

https://doi.org/10.1182/blood.V108.11.3497.3497

Published: 2006

Journal Articles

Novel Model To Evaluate Changes in Gene Expression Profile of Myeloma Cells In Vivo Following Interaction with Human BM Microenvironment.

Paola Neri, MD, Pierfrancesco Tassone, MD, Masood A. Shammas, PhD, Daniel R. Carrasco, MD, Renate Burger, PhD, Constantine S. Mitsdiades, MD, Simona Blotta, MD, Rao H. Prabhala, PhD, Laurence Catley, MD, Salvatore Venuta, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2005) 106 (11): 2490.

https://doi.org/10.1182/blood.V106.11.2490.2490

Published: 2005

Journal Articles

Alkylphosphocholine Perifosine Inhibits Myeloma Cell Growth While Inducing Myeloid Hyperplasia in a Murine Myeloma Model.

Laurence Catley, MBBS, FRACP, FRCPA, Teru Hideshima, MD, PhD, Dharminder Chauhan, JD, PhD, Paola Neri, MD, Piefrancesco Tassone, MD, Yu-Tzu Tai, PhD, Weihua Song, MD, Daniel R. Carrasco, MD, PhD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD

Blood (2005) 106 (11): 1579.

https://doi.org/10.1182/blood.V106.11.1579.1579

Published: 2005

Journal Articles

A Clinically Relevant SCID-hu in Vivo Model of Human Multiple Myeloma.

Pierfrancesco Tassone, MD, Paola Neri, MD, Daniel R. Carrasco, MD, Renate Burger, PhD, Laurence Catley, MD, Salvatore Venuta, MD, PhD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2004) 104 (11): 2455.

https://doi.org/10.1182/blood.V104.11.2455.2455

Published: 2004

NARROW

Bcl6 as a Novel Therapeutic Target in Multiple Myeloma (MM).

A NOVEL Aurora A Kinase INHIBITOR MLN8237 Induces Cytotoxicity and CELL Cycle Arrest IN MULTIPLE MYELOMA.

RFP2 Knockdown Disrupts Cell Growth and Induces Apoptosis in Multiple Myeloma

ß-Catenin Is a Novel Marker of the Aggresome and Suggests Disruption of the Proteasome-Aggresome-Autophagasome Pathway in Multiple Myeloma In Vivo.

Clonotypic Bone Marrow-Derived Endothelial Progenitor Cells in Multiple Myeloma.

Novel Model To Evaluate Changes in Gene Expression Profile of Myeloma Cells In Vivo Following Interaction with Human BM Microenvironment.

Alkylphosphocholine Perifosine Inhibits Myeloma Cell Growth While Inducing Myeloid Hyperplasia in a Murine Myeloma Model.

A Clinically Relevant SCID-hu in Vivo Model of Human Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only